Apimeds Pharmaceuticals US Inc. 今日宣布,其已确认Inscobee Inc. (Ks:006490) 与Apimeds Inc. 严重违反了双方此前达成的合并协议条款。鉴于此重大违约行为,该公司正在准备相关法律文件,计划向特拉华州衡平法院提起紧急诉讼,以维护其合法权益。
Apimeds Pharmaceuticals US Inc. 今日宣布,其已确认Inscobee Inc. (Ks:006490) 与Apimeds Inc. 严重违反了双方此前达成的合并协议条款。鉴于此重大违约行为,该公司正在准备相关法律文件,计划向特拉华州衡平法院提起紧急诉讼,以维护其合法权益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.